✅ New API: 6000+ US Stock Options End-of-Day Data with 40+ fields. Learn more

NGeneBio Co. Ltd. (354200 KQ) stock market data APIs

₩1794.7473 3.05(0.2%)
as of September 18, 2025
Try our APIs with free plan!

NGeneBio Co. Ltd. Financial Data Overview

Price chart is built with Anychart
OpenFigi: BBG00Y1Q**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

NGeneBio Co., Ltd. develops in vitro diagnostics companion diagnostics products and bioinformatics software. It offers BRCAaccuTest and BRCAaccuTest PLUS are reagent kits for breast and ovarian cancer, and hereditary breast and ovarian cancer syndrome; HEMEaccuTest, a clinical NGS kit for hematological malignancies, such as acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic/myeloproliferative neoplasm, multiple myeloma, and lymphoma; SOLIDaccuTest, a genetic variants screening for solid tumors; HLAaccuTest, an in vitro diagnostic medical device for human leukocyte antigen typing; and OncoaccuPanel, a solid tumor oncology next generation sequencing test. The company also provides NGeneAnalySys, a software for analysis of the genetic testing data; and EasyHLAanalyzer, which offers the HLA typing identifing human leukocyte antigen for histocompatibility antigens using data from NGS. In addition, it offers IDaccuTest, a short tandem repeat test for family relationship testing, identity testing, forensics, and chimerism analysis; and NGenePlex nCoV qRT-PCR Kit, a reagent of real-time reverse transcription-polymerase chain reaction assay intended for the qualitatively detecting nucleic acid of SARS-CoV-2 from patients infected or suspected of COVID-19. The company was founded in 2015 and is headquartered in Seoul, South Korea.

Prev. Close 1794.7473
Open 1797.7987
High 1803.2425
Low 1797.7987
52 wk Range 1503-5015.5332
Market Cap 45 069 M
Shares Outstanding 25 038 K
Revenue 6 628 M
EPS -269.9471
Beta 1.203

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get NGeneBio Co. Ltd. data using free add-ons & libraries


Get NGeneBio Co. Ltd. Fundamental Data

NGeneBio Co. Ltd. Fundamental data includes:

  • Net Revenue: 6 628 M
  • EBITDA: -11 279 976 448
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get NGeneBio Co. Ltd. Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-06-30
  • EPS/Forecast: NaN
GET THE PACKAGE

Get NGeneBio Co. Ltd. End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat